{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:16Z","timestamp":1707524236907},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,2]]},"DOI":"10.7759\/cureus.12432","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T19:01:52Z","timestamp":1609614112000},"source":"Crossref","is-referenced-by-count":0,"title":["Guillain-Barre Syndrome Amid Osteosarcoma Treatment: A Therapeutic Dilemma and Literature Review"],"prefix":"10.7759","author":[{"given":"Geraldine","family":"Peralta Suarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Tinoco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barre syndrome","volume":"92","author":"Wijdicks EF","year":"2017","unstructured":"Wijdicks EF, CJ Klein. Guillain-Barre syndrome. Mayo Clin Proc. 2017, 92:467-479. 10.1016\/j.mayocp.2016.12.002","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52902-2.00021-7","article-title":"The Guillain-Barr\u00e9 syndrome","volume":"115","author":"Fujimura H","year":"2013","unstructured":"Fujimura H. The Guillain-Barr\u00e9 syndrome. Handb Clin Neurol. 2013, 115:383-402. 10.1016\/B978-0-444-52902-2.00021-7","journal-title":"Handb Clin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.053","article-title":"Guillain-Barre syndrome after vaccination in United States a report from the CDC\/FDA Vaccine Adverse Event Reporting System","volume":"25","author":"Souayah N","year":"2007","unstructured":"Souayah N, Nasar A, Suri MFK, Qureshi AI. Guillain-Barre syndrome after vaccination in United States a report from the CDC\/FDA Vaccine Adverse Event Reporting System. Vaccine. 2007, 25:5253-5255. 10.1016\/j.vaccine.2007.03.053","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000451","article-title":"Clinical factors associated with Guillain-Barr\u00e9 syndrome following surgery","volume":"8","author":"Hocker S","year":"2018","unstructured":"Hocker S, Nagarajan E, Rubin M, Wijdicks EFM. Clinical factors associated with Guillain-Barr\u00e9 syndrome following surgery. Neurol Clin Pract. 2018, 8:201-206. 10.1212\/CPJ.0000000000000451","journal-title":"Neurol Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006246","article-title":"Surgery and risk of Guillain-Barr\u00e9 syndrome: a French nationwide epidemiologic study","volume":"91","author":"Rudant J","year":"2018","unstructured":"Rudant J, Dupont A, Mikaeloff Y, et al.. Surgery and risk of Guillain-Barr\u00e9 syndrome: a French nationwide epidemiologic study. Neurology. 2018, 91:1220-1227. 10.1212\/WNL.0000000000006246","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.09.008","article-title":"Guillain-Barre syndrome occurring after adjuvant chemo-radiotherapy for endometrial cancer","volume":"100","author":"Tho LM","year":"2006","unstructured":"Tho LM, O\u00b4Leary CP, Horrocks I, Al-Ani A, Reed NS. Guillain-Barre syndrome occurring after adjuvant chemo-radiotherapy for endometrial cancer. Gynecol Oncol. 2006, 100:615-617. 10.1016\/j.ygyno.2005.09.008","journal-title":"Gynecol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/02841860701877330","article-title":"Weakness and numbness after chemotherapy for metastatic non-seminoma testis: a new neurological complication","volume":"47","author":"Verdonk RC","year":"2008","unstructured":"Verdonk RC, Enting RH, Janmaat M, Schroder CP, Sleijfer DT, Gietema JA. Weakness and numbness after chemotherapy for metastatic non-seminoma testis: a new neurological complication. Acta Oncol. 2008, 47:1596-1568. 10.1080\/02841860701877330","journal-title":"Acta Oncol"},{"key":"ref8","unstructured":"National Comprehensive Cancer Network - Bone Cancer (Version 1.2020). Accessed. July 1, 2020: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bone.pdf."},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.27651","article-title":"Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma","volume":"118","author":"Bernthal NM","year":"2012","unstructured":"Bernthal NM, Federman N, Eilber FR, et al.. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma. Cancer. 2012, 118:5888-5893.","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8053.1","article-title":"Chemotherapy-induced peripheral neuropathy: an update on the current understanding","volume":"5","author":"Addington J","year":"2016","unstructured":"Addington J, Freimer M. Chemotherapy-induced peripheral neuropathy: an update on the current understanding. F1000Res. 2016, 5:10.12688\/f1000research.8053.1","journal-title":"F1000Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl356","article-title":"Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies","volume":"130","author":"Krarup-Hansen A","year":"2007","unstructured":"Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, R\u00f8rth M, Krarup C. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain. 2007, 130:1076-1088. 10.1093\/brain\/awl356","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200411000-00010","article-title":"Guillain-Barre syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy","volume":"15","author":"Christodoulou C","year":"2004","unstructured":"Christodoulou C, Anastasopoulos D, Visvikis A, et al.. Guillain-Barre syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy. Anticancer Drugs. 2004, 15:997-999. 10.1097\/00001813-200411000-00010","journal-title":"Anticancer Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2006.18.3.325","article-title":"A case of Guillain-Barr\u00e9 syndrome in a patient with non small cell lung cancer treated with chemotherapy","volume":"18","author":"Cicero G","year":"2006","unstructured":"Cicero G, Fulfaro F, Caraceni A, et al.. A case of Guillain-Barr\u00e9 syndrome in a patient with non small cell lung cancer treated with chemotherapy. J Chemother. 2006, 18:325-327. 10.1179\/joc.2006.18.3.325","journal-title":"J Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.04.014","article-title":"Guillain-Barr\u00e9 syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy","volume":"23","author":"Koshikawa H","year":"2017","unstructured":"Koshikawa H, Tsukie T, Kurita A, et al.. Guillain-Barr\u00e9 syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy. J Infect Chemother. 2017, 23:798-799. 10.1016\/j.jiac.2017.04.014","journal-title":"J Infect Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000437295","article-title":"Paraneoplastic Guillain-Barr\u00e9 syndrome in small cell lung cancer","volume":"8","author":"Kim MH","year":"2015","unstructured":"Kim MH, Hwang MS, Park Y, et al.. Paraneoplastic Guillain-Barr\u00e9 syndrome in small cell lung cancer. Case Rep Oncol. 2015, 8:295-300. 10.1159\/000437295","journal-title":"Case Rep Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0255","article-title":"Guillain-Barr\u00e9 syndrome during platinum-based chemotherapy: a case series and review of the literature","volume":"25","author":"Pappa E","year":"2020","unstructured":"Pappa E, Berzero G, Herlin B, et al.. Guillain-Barr\u00e9 syndrome during platinum-based chemotherapy: a case series and review of the literature. Oncologist. 2020, 25:194-197. 10.1634\/theoncologist.2019-0255","journal-title":"Oncologist"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2007.00134.x","article-title":"Guillain-Barre syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma","volume":"12","author":"Terenghi F","year":"2007","unstructured":"Terenghi F, Ardolino G, Nobile-Orazio E. Guillain-Barre syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma. J Peripher Nerv Syst. 2007, 12:142-143. 10.1111\/j.1529-8027.2007.00134.x","journal-title":"J Peripher Nerv Syst"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-8-455","article-title":"Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barre syndrome: a case report","volume":"8","author":"Hughes CL","year":"2014","unstructured":"Hughes CL, Yorio JT, Kovitz C, Oki Y. Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barre syndrome: a case report. J Med Case Rep. 2014, 8:455. 10.1186\/1752-1947-8-455","journal-title":"J Med Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.02.003","article-title":"A retrospective analysis of possible triggers of Guillain-Barre syndrome","volume":"293","author":"Yang B","year":"2016","unstructured":"Yang B, Lian Y, Liu Y, Wu BY, Duan RS. A retrospective analysis of possible triggers of Guillain-Barre syndrome. J Neuroimmunol. 2016, 293:17-21. 10.1016\/j.jneuroim.2016.02.003","journal-title":"J Neuroimmunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.040378","article-title":"Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage","volume":"75","author":"Rees JH","year":"2004","unstructured":"Rees JH. Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry. 2004, 75:43-50. 10.1136\/jnnp.2004.040378","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/47557-guillain-barre-syndrome-amid-osteosarcoma-treatment-a-therapeutic-dilemma-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:35Z","timestamp":1707506855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/47557-guillain-barre-syndrome-amid-osteosarcoma-treatment-a-therapeutic-dilemma-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12432","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,2]]}}}